From Code to Cure: The Impact of Artificial Intelligence in Pharma

Naga Santhosh Reddy Vootukuri, R. Harichandana, K. Sai Prasanna and V. Jeevana Jyothi

Chapter 3 in Convergence of Technology & Biology ─ Transforming Life Sciences, 2025, pp 22-31 from Shanlax Publications

Abstract: Artificial Intelligence (AI) is revolutionizing the field of drug discovery and development by making it faster, more accurate, and cost-effective. By analysing vast amounts of biomedical data, AI can quickly identify potential drug candidates, predict how drugs will interact with targets, and assist in designing new molecules. This speeds up the process of bringing new drugs to market. AI also helps in optimizing clinical trials and improving drug formulations. However, there are challenges such as data bias, regulatory issues, and ethical concerns. Despite these, AI holds great promise for the future, including personalized medicine and advanced research using quantum computing and AI-powered labs. This paper highlights the latest advancements and the transformative impact of AI on the pharmaceutical industry.

Date: 2025
ISBN: 978-93-6163-763-6
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.shanlaxpublications.com/p/ctbtls/ch003.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dax:ctbtls:978-93-6163-763-6:p:22-31

Access Statistics for this chapter

More chapters in Convergence of Technology & Biology ─ Transforming Life Sciences from Shanlax Publications Madurai, Tamil Nadu, India.
Bibliographic data for series maintained by S.Lakshmanan ().